Clinical Research On The Wei Tiao San Hao Decoction Jointed Chemotherapy GEMOX Treating Advanced Pancreatic Cancer

Objective: To observe the clinical effect of Wei Tiao San Hao decoction (WD-3) in the treatment of advanced pancreatic cancer clinical benefit response, short-term efficacy and quality of life of patients with clinical symptoms common to improve the situation, the impact of tumor targets and reduce the toxicity of chemotherapy role.Methods: Using randomized controlled methods of observation of 40 cases of advanced pancreatic cancer patients, divided into WD-3 + chemotherapy group (ie treatment group) and the standard chemotherapy control group, 20 cases in each group. The treatment group takes Wei Tiao San Hao decoction (WD-3) and with chemotherapy GEMOX; control group are given chemotherapy GEMOX alone..In accordance with the evaluation criteria, the two groups are observed after treatment of patients with clinical benefit response, quality of life, clinical symptoms common to improve the situation, tumor targets (CEA, CA19-9) changes in the near future the objective efficacy and toxicity of chemotherapy, and statistical analysis of the two group differences in the above-mentioned indicators.Results: The treatment group in response to improve clinical benefit response, improve quality of life, alleviate symptoms, reduce the toxicity of chemotherapy response, compared with the control group, the difference has statistical significance. Efficacy in the near future, the two groups have therapeutic equivalence; disease control rate of the control group, there is a significant difference between the two groups. The two groups on the impact of target tumor was no significant difference.Conclusion: Wei Tiao San Hao decoction(WD-3) in the treatment of advanced pan- creatic cancer patients can improve clinical benefit response, ease pain, improve physical condition; to improve patients quality of life and mitigate the common clinical symptoms; able to control tumor growth, stabilize lesions, improve disease control rate; can reduce the toxicity of chemotherapy to ensure the smooth completion of chemotherapy.